Correction: Risk of hepatitis B virus reactivation in the treatment of HBsAg and HBV DNA double-negative lymphoma patients. . PLoS One 2026;21:e0356789.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Correction: Risk of hepatitis B virus reactivation in the treatment of HBsAg and HBV DNA double-negative lymphoma patients. PLoS One 2026;21:e0356789.
PMID: 42623378